MediSave and insurance generally do not cover GLP-1 for weight loss in Singapore: obesity is not one of MediSave's 23 outpatient chronic conditions (MOH). The two Integrated Shield Plan wordings checked exclude treatment for obesity and weight reduction (Singlife, Prudential). MOH's CDMP Handbook lists weight-loss medication as claimable for obese patients with a covered condition such as diabetes, if clinically indicated, and elsewhere as not claimable.
At GetLean the programme is from S$288 a month: one monthly fee covers your consultations with Dr Quek, the medication and daily WhatsApp coaching, with no lock-in. The first video consultation is S$20, refunded in full if Dr Quek decides GLP-1 medication is not right for you, and a consultation does not guarantee a prescription.
CDMP: the Chronic Disease Management Programme, MOH's list of chronic conditions whose outpatient treatment can be paid for with MediSave. It covers 23 conditions as of October 2026 (MOH).
Is obesity covered by MediSave?
Not as a condition in its own right; surgery is a separate case, covered below. MOH's list of 23 CDMP conditions includes diabetes, hypertension and lipid disorders, and does not include obesity (MOH). MOH's guidance for doctors names the first condition as "Diabetes Mellitus / Pre-diabetes" (MOH).
For those conditions, MediSave can currently pay up to S$500 a year per patient, or S$700 for complex chronic conditions (MOH). A patient counts as complex if treated for two or more CDMP conditions in a visit, or for one with a recognised complication (MOH). Each claim carries a 15% cash co-payment, waived since 1 February 2024 at the patient's enrolled Healthier SG clinic (MOH, MOH).
From 1 January 2027 the scheme is renamed "MediSave Chronic and Preventive Care", the limits rise to S$700 and S$1,000, and hyperthyroidism and hypothyroidism join the list (MOH). Obesity is not among the additions.
Claims can only be made at MediSave-accredited healthcare entities: all polyclinics, all public hospitals' specialist outpatient clinics, and accredited specialist and GP clinics (MOH).
Can MediSave pay for weight-loss medication if you have diabetes or high blood pressure?
MOH's handbook for the scheme points both ways, and it does not settle the question for GLP-1 medicines. Its list of claimable items includes "weight-loss medications for obese patients if clinically indicated based on prevailing local guidelines" for the relevant conditions (CDMP Handbook). Under six conditions (diabetes and pre-diabetes, hypertension, lipid disorders, chronic kidney disease, stroke and osteoarthritis) it lists "Drug therapy for weight management (e.g. orlistat), as an adjunctive to lifestyle modification and combined with diet and physical activity, when BMI is ≥ 27.5 kg/m2" as claimable.
The same handbook lists as not claimable "Lifestyle-modifying medications (e.g., hair-loss or weight-loss medications)", "Off-label use of medications", "Non-HSA registered medications", and "Slimming pills if BMI < 27.5kg/m2". It says claims will generally not be allowed for "slimming pills ... used for lifestyle purposes", and it lists "Commercial weight management programmes / exercise support (e.g. gym classes)" as not claimable (CDMP Handbook).
Whether a GLP-1 medicine prescribed for weight counts as a claimable weight-loss medication is not stated. The handbook's only named weight-management drug is orlistat, and its one mention of GLP-1 medicines is about type 2 diabetes and heart and kidney risk, not weight (CDMP Handbook).
Two conditions run through every claim. The doctor must document the link between the approved condition and its treatment, and only the accredited clinic and its doctors can submit the claim on the patient's behalf (CDMP Handbook). So the clinic managing the diabetes, hypertension or lipid disorder is the one that can say what it will claim.
Are GLP-1 medicines subsidised at polyclinics or under Healthier SG?
Not for weight. HSA describes GLP-1 medicines as prescription-only medicines approved to treat type 2 diabetes and/or weight management in obese or overweight people with weight-related health problems (HSA). MOH's list of subsidised drugs, which applies at public hospitals, specialist outpatient clinics and polyclinics, has no semaglutide, liraglutide, tirzepatide or orlistat as of 1 September 2026. The one GLP-1 medicine on it is dulaglutide, in the Medication Assistance Fund class, for type 2 diabetes under stated conditions (MOH).
The Healthier SG medication list is drawn from medicines commonly used in polyclinics for CDMP conditions (Healthier SG). MOH's dataset of that list, updated 29 September 2026, has 224 entries; its only GLP-1 medicines are two dulaglutide pens, and it has no semaglutide, liraglutide, tirzepatide or orlistat (Healthier SG list).
CHAS follows the same set of chronic conditions as the CDMP (CHAS), so obesity is not a CHAS chronic condition either. Both drug lists change over time; these were read on 7 October 2026.
Does MediShield Life or an Integrated Shield Plan cover it?
The two Integrated Shield policy wordings checked exclude it, and MediShield Life has no outpatient item for it. An Integrated Shield Plan is a private plan that adds cover on top of MediShield Life, and MediShield Life is included in every one (MOH).
MediShield Life's outpatient benefits are a list of specific treatments, such as cancer drug treatment, radiotherapy and kidney dialysis, and the list has no weight-loss medication item (MOH).
Singlife Shield's 2026 policy lists among what it does not cover "treatment for obesity, weight reduction, weight improvement or procedure for weight management" (Singlife). Prudential lists among the PRUShield general exclusions "Treatment relating to obesity; weight reduction; weight improvement or procedures relating to weight management" (Prudential). Other insurers' plans have their own wording, so the exclusions section of your own policy is the place to check.
What about company medical benefits?
It depends on the employer's plan. Under the Employment Act, for an employee who has worked there for at least 3 months, the employer must pay the medical consultation fee when the consultation results in at least one day of paid sick leave and the medical certificate comes from a public medical institution or a practitioner the company appointed (MOM). Beyond that, the Ministry of Manpower says some employers provide wider medical benefits and that employees should check their employment contract for the details (MOM). The benefits booklet is where any cover, or exclusion, for weight-loss medication will be written.
Is bariatric surgery covered?
Yes, within limits. MediSave and MediShield Life claims for surgery are made against MOH's Table of Surgical Procedures, an exhaustive list in which any procedure not listed is not claimable, and it lists obesity operations with a table rank (TOSP).
| Operation (TOSP code) | Table | MediSave surgical limit |
|---|---|---|
| Sleeve gastrectomy (SF703S) | 5B | S$2,660 |
| Stomach reduction and bypass (SF804S) | 5C | S$2,770 |
| Gastric banding (SF702S) | 5C | S$2,770 |
| Endoscopic sleeve gastroplasty (SF815S) | 3C | S$1,920 |
The MediSave limit for an admission is the surgical limit plus the daily hospital charge limit, up to S$1,130 a day for the first two days and S$400 a day from the third (MOH). MediShield Life's surgical limit for tables 5B and 5C is S$3,270 (MOH). Singlife's wording notes that where an exclusion is covered under MediShield Life, the claim is dealt with on MediShield Life's terms and limits (Singlife). The clinical criteria for surgery are not set out in these MOH pages.
How surgery and medication compare as treatments is covered in GLP-1 or bariatric surgery, and who qualifies for GLP-1 treatment in the BMI thresholds used in Singapore.
These schemes change, and the figures above are as published on 7 October 2026. The limits rise on 1 January 2027, and both drug lists are updated regularly.
Common questions
Can I use MediSave for GLP-1 weight-loss medication?
Obesity is not one of the 23 conditions MediSave's outpatient scheme covers. MOH's rulebook for those conditions lists weight-loss medication for obese patients with a covered condition, such as diabetes, as claimable if clinically indicated, but also lists weight-loss medication as not claimable, and it does not say whether a GLP-1 medicine for weight counts.
Is obesity a CDMP condition?
No. The 23 CDMP conditions include diabetes with pre-diabetes, hypertension and lipid disorders, but not obesity. The changes MOH announced for January 2027 add hyperthyroidism and hypothyroidism, and obesity is not among them.
Are GLP-1 medicines for weight subsidised at polyclinics or under Healthier SG?
Semaglutide, liraglutide and tirzepatide are not on MOH's list of subsidised drugs as of 1 September 2026, nor on the Healthier SG medication list updated 29 September 2026. The only GLP-1 medicine on either list is dulaglutide, for type 2 diabetes.
Does an Integrated Shield Plan cover weight-loss treatment?
The Singlife Shield and Prudential PRUShield wordings exclude treatment for obesity and weight reduction. MediShield Life, which sits inside every Integrated Shield Plan, has an outpatient list of specific treatments with no weight-loss item. Other plans have their own wording, so the exclusions in your own policy decide.
Does MediSave cover bariatric surgery?
Obesity operations are listed in MOH's Table of Surgical Procedures, which is the list MediSave and MediShield Life claims for surgery are made against. A sleeve gastrectomy is ranked 5B, with a MediSave surgical limit of S$2,660, plus daily hospital charge limits.
Does company insurance cover GLP-1 medication?
It depends on the plan. The Ministry of Manpower says some employers provide medical benefits beyond what the Employment Act provides for and that employees should check their employment contract, so the employer's benefits documents are where the answer is.